Themis Medicare Limited has informed the Exchange regarding Notice of Postal Ballot
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has issued a corrigendum to its Postal Ballot Notice dated 25 February 2026, which originally sought shareholder approval to issue convertible equity warrants on a preferential basis to Vividhmargi Investments Private Limited (VMIPL), a promoter group company. The revision follows observations raised by NSE on the company's in-principle approval application. The warrant issue price has been increased from Rs. 100 to Rs. 102.87 per warrant, raising the total issue size from Rs. 45.96 crore to Rs. 47.28 crore, while the number of warrants remains unchanged at 45,95,795. The 25% upfront subscription amount has been revised to Rs. 11.82 crore (from Rs. 11.49 crore) and the 75% balance at exercise to Rs. 35.46 crore. The new price reflects the recalculated 90-trading-day VWAP-based floor price under SEBI ICDR Regulations. Shareholders who have already cast their votes may modify them by emailing the scrutinizer before e-voting closes on 27 March 2026 at 5:00 PM.
The corrigendum is a procedural price correction rather than a change in deal size or scope—existing shareholders face a marginally higher dilution value but the warrant count and counterparty (promoter group) stay the same. Investors should review the revised pricing and may revise their votes before the 27 March deadline if they wish.